Information Provided By: 
Fly News Breaks for August 16, 2016
PODD
Aug 16, 2016 | 06:36 EDT
Piper Jaffray analyst Brooks West raised his price target for Insulet to $52 after attending the American Association of Diabetes Educators annual meeting. The analyst says his checks on Insulet indicate continued strength for the core OmniPod business. Patients, educators and even direct competitors have noticed a "meaningful uptick" in product quality as well as improvements in the company's end-to-end operations, West tells investors in a research note. He reiterates an Overweight rating on the shares.
News For PODD From the Last 2 Days
There are no results for your query PODD
